References
- Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475–87.
- Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, et al. Primary and secondary surveys on epidemiology on Sjögren's syndrome in Japan. Mod Rheumatol. 2013 [Epub ahead of print].
- Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69(6):1103–9.
- Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjögren's syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome. Ann Rheum Dis 2011;70(6):968–72.
- Izumi M, Eguchi K, Ohki M, Uetani M, Hayashi K, Kita M, et al. MR imaging of the parotid gland in Sjögren's syndrome: a proposal for new diagnostic criteria. Am J Roentgenol. 1996;166(6): 1483–7.
- Späth M, Krüger K, Dresel S, et al. Magnetic resonance imaging of the parotid gland in patients with Sjögren's syndrome. J Rheumatol. 1991;18(9):1372–8.
- Takashima S, Takeuchi N, Morimoto S, Tomiyama N, Ikezoe J, Shogen K, et al. MR imaging of Sjögren syndrome: correlation with sialography and pathology. J Comput Assist Tomogr. 1991;15(3): 393–400.
- Valesini G, Gualdi GF, Priori R, Di Biasi C, Polettini E, Trasimeni G, et al. Magnetic resonance imaging of the parotid glands and lip biopsy in the evaluation of xerostomia in Sjögren's syndrome. Scand J Rheumatol. 1994;23(2):103–6.
- Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T. Premature fat deposition in the salivary glands associated with Sjögren syndrome: MR and CT evidence. AJNR Am J Neuroradiol 1997;18(5):951–8.
- Morimoto Y, Habu M, Tomoyose T, Ono K, Tanaka T, Yoshioka I, et al. Dynamic magnetic resonance sialography as a new diagnostic technique for patients with Sjögren's syndrome. Oral Dis 2006;12: 408–14.
- Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S. A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J Comput Assist Tomogr. 2001;25(2):262–8.
- Tonami H, Ogawa Y, Matoba M, Kuginuki Y, Yokota H, Higashi K, et al.MR sialography in patients with Sjögren syndrome. AJNR Am J Neuroradiol. 1998;19(7):1199–203.
- Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol. 2004;14(6):425–34.
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569–81.
- Rubin P, Holt JF. Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1957;77(4):575–98.
- Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974;37(2):217–29.
- Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.
- Roberts C, Parker GJ, Rose CJ, Watson Y, O’Connor JP, Stivaros SM, et al. Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling–initial experience. Radiology 2008;246(3):845–53.
- EI Miedany YM, Ahmed I, Mourad HG, Mehanna AN, Aty SA, Gamal HM, et al. Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjögren's syndrome? Joint Bone Spine 2004; 71(1):29–38.
- Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG. The future of biologic agents in the treatment of Sjögren's syndrome. Clin Rev Allergy Immunol. 2007;32(3):292–7.
- Ramos-Casals M, Brito-Zerón P. Emerging biological therapies in primary Sjogren's syndrome. Rheumatology (Oxford). 2007;46(9):1389–96.
- Vissink A, Kallenberg CG, Bootsma H. Treatment approaches in primary Sjogren syndrome. JAMA 2010;304(18):2015–6.
- Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 2011;13(4):227.